Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey.

Anhang Price R, Tiro JA, Saraiya M, Meissner H, Breen N.

Cancer. 2011 Dec 15;117(24):5560-8. doi: 10.1002/cncr.26244. Epub 2011 Jul 5.

2.

National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2010 Aug 20;59(32):1018-23.

3.

Cervical cancer prevention: new tools and old barriers.

Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, Dignan M, Ma GX, Daye JL, Castle PE.

Cancer. 2010 Jun 1;116(11):2531-42. doi: 10.1002/cncr.25065. Review.

4.

Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.

Meissner HI, Tiro JA, Yabroff KR, Haggstrom DA, Coughlin SS.

Med Care. 2010 Mar;48(3):249-59. doi: 10.1097/MLR.0b013e3181ca4015.

PMID:
20182268
5.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
6.

ACOG Practice Bulletin no. 109: Cervical cytology screening.

ACOG Committee on Practice Bulletins--Gynecology..

Obstet Gynecol. 2009 Dec;114(6):1409-20. doi: 10.1097/AOG.0b013e3181c6f8a4. No abstract available.

PMID:
20134296
7.

Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization.

Chao C, Velicer C, Slezak JM, Jacobsen SJ.

Am J Epidemiol. 2010 Feb 1;171(3):357-67. doi: 10.1093/aje/kwp365. Epub 2010 Jan 4.

8.

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

GlaxoSmithKline Vaccine HPV-007 Study Group., Romanowski B, de Borba PC, Naud PS, Roteli-Martins CM, De Carvalho NS, Teixeira JC, Aoki F, Ramjattan B, Shier RM, Somani R, Barbier S, Blatter MM, Chambers C, Ferris D, Gall SA, Guerra FA, Harper DM, Hedrick JA, Henry DC, Korn AP, Kroll R, Moscicki AB, Rosenfeld WD, Sullivan BJ, Thoming CS, Tyring SK, Wheeler CM, Dubin G, Schuind A, Zahaf T, Greenacre M, Sgriobhadair A.

Lancet. 2009 Dec 12;374(9706):1975-85. doi: 10.1016/S0140-6736(09)61567-1.

PMID:
19962185
9.

Pap testing and sexual activity among young women in the United States.

Saraiya M, Martinez G, Glaser K, Kulasingam S.

Obstet Gynecol. 2009 Dec;114(6):1213-9. doi: 10.1097/AOG.0b013e3181be3db4.

PMID:
19935021
10.

Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

Yabroff KR, Saraiya M, Meissner HI, Haggstrom DA, Wideroff L, Yuan G, Berkowitz Z, Davis WW, Benard VB, Coughlin SS.

Ann Intern Med. 2009 Nov 3;151(9):602-11. doi: 10.7326/0003-4819-151-9-200911030-00005.

PMID:
19884621
11.

Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey.

Caskey R, Lindau ST, Alexander GC.

J Adolesc Health. 2009 Nov;45(5):453-62. doi: 10.1016/j.jadohealth.2009.04.021. Epub 2009 Jun 24.

PMID:
19837351
12.

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR.

Int J Gynecol Cancer. 2009 Oct;19(7):1166-76. doi: 10.1111/IGC.0b013e3181a3d100. Review.

PMID:
19823051
13.

Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination.

Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA.

J Womens Health (Larchmt). 2009 Oct;18(10):1679-86. doi: 10.1089/jwh.2008.1329.

PMID:
19785564
14.

Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls.

Chao C, Slezak JM, Coleman KJ, Jacobsen SJ.

Am J Public Health. 2009 Jun;99(6):1137-42. doi: 10.2105/AJPH.2008.147876. Epub 2009 Apr 16.

15.

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L.

Prev Med. 2009 May;48(5):426-31. doi: 10.1016/j.ypmed.2008.11.010. Epub 2008 Dec 6.

PMID:
19100762
16.

Human papillomavirus and cervical cancer behavioral surveillance in the US.

Tiro JA, Saraiya M, Jain N, Liddon N, Cokkinides V, Lai SM, Breen N, Wideroff L.

Cancer. 2008 Nov 15;113(10 Suppl):3013-30. doi: 10.1002/cncr.23760. Review.

17.

Burden of cervical cancer in the United States, 1998-2003.

Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, Schwenn M, Huang Y, Giuliano A.

Cancer. 2008 Nov 15;113(10 Suppl):2855-64. doi: 10.1002/cncr.23756.

18.

Health and economic implications of HPV vaccination in the United States.

Kim JJ, Goldie SJ.

N Engl J Med. 2008 Aug 21;359(8):821-32. doi: 10.1056/NEJMsa0707052.

19.

The role of health insurance coverage in cancer screening utilization.

Robinson JM, Shavers V.

J Health Care Poor Underserved. 2008 Aug;19(3):842-56. doi: 10.1353/hpu.0.0048.

PMID:
18677074
20.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC).; Advisory Committee on Immunization Practices (ACIP)..

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

Supplemental Content

Support Center